| PERIOD ENDING | 30-Jun-09 | 30-Jun-08 | 30-Jun-07 | | Total Revenue | 11,119 | 9,628 | 5,427 | | Cost of Revenue | 9,025 | 7,782 | 5,534 | | | Gross Profit | 2,094 | 1,846 | (107) | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 1,932 | 1,751 | 1,575 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 162 | 96 | (1,682) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (19) | 26 | 5 | | Earnings Before Interest And Taxes | 143 | 122 | (1,677) | | Interest Expense |
-
|
-
| 5 | | Income Before Tax | 143 | 122 | (1,682) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 143 | 122 | (1,682) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 143 | 122 | (1,682) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $143 | $122 | ($1,682) |
|
0.51% Nasdaq 
Income Statement
